Atrial Fibrillation Clinical Trial
Official title:
RADAR: Effect of Structural Remodeling on Scar Formation as Assessed by DE-MRI of the Left Atrium Following Open-Irrigation Cooled-Tip Radiofrequency Catheter Ablation of Paroxysmal Atrial Fibrillation
The purpose of this study is to evaluate the impact of pre-ablation fibrosis on scar formation in the left atrium of the heart. This will be assessed by delayed enhancement magnetic resonance imaging and will be looked at in patients who have undergone successful open irrigated cooled-tipped radio-frequency ablation of paroxysmal atrial fibrillation. Follow-up after ablation will be for 12 months.
Atrial fibrillation (AF) is an electrophysiological condition characterized by disorganized
electrical activity that involves the entire atria. AF manifests initially as paroxysms of
arrhythmia that later progress into persistent and permanent forms. It is a progressive
disease associated with structural, electrical and contractile changes in the left atrium
(LA). A major determinant of the progression of AF is structural remodeling or fibrosis that
occurs in the left atrium. A more extensively remodeled atrium presents the substrate needed
for the arrhythmia to persist. Structural remodeling is also a major determinant for success
of rhythm control strategies in AF. While catheter ablation has reproducibly been shown to
be superior to anti-arrhythmic drug (AAD) therapy for rhythm control in AF, the success of
this procedure is significantly affected by the extent of structural remodeling present at
the time of catheter ablation.
Delayed-Enhancement Magnetic Resonance Imaging (DE-MRI) has been demonstrated to be a very
effective modality in identifying fibrotic and scarred cardiac tissue with excellent
correlation to electro-anatomical mapping. This is related to the characteristics of
Gadolinium, an extracellular contrast agent that is very effective in identifying regions of
fibrotic non-viable myocardium. DE-MRI technology can be a very powerful, non-invasive
method, of identifying the extent and the distribution of structural remodeling or fibrosis
associated with AF. Specific image acquisition sequences have allowed for reproducible
identification of high pixel intensity regions within the 2-dimensional images of the atrial
wall. 3-Dimensional reconstruction of the entire left atrium then provides a quantification
of the overall volume occupied by these hyper-enhanced regions relative to the entire left
atrial wall volume. Used prior to catheter ablation, DE-MRI can therefore identify regions
of significant structural remodeling or fibrosis. The same technology has also been shown to
be very useful in examining the amount and distribution of ablation-induced scarring.
Catheter ablation has emerged as an effective interventional therapeutic modality for AF
patients. Current ablation techniques, including pulmonary vein antrum isolation (PVAI), use
radiofrequency (RF) energy to induce thermal damage to the LA substrate in an attempt to
electrically disconnect and isolate arrhythmogenic foci originating from the pulmonary veins
(PVs). Multiple catheter technologies for RF have been developed. Catheters may be either
cooled or not. Cooling allows for higher and deeper energy delivery with larger lesion
formation. Open irrigation cooled-tip RF ablation of AF is associated with less impedance
rise, microbubble formation, and esophageal injury when compared with traditional non-cooled
ablation catheters. It is also associated with shorter RF delivery time, fluoroscopy, and
procedural time.
Understanding the temporal sequence of events of LA structural remodeling (preceding AF
ablation) to scar formation (following AF ablation) can prove valuable in determining
whether certain patients are more susceptible to recovery of electrical conduction and
recurrence of AF. DE-MRI recently has been introduced as a means to visualize this
RF-induced scarring post-ablation. These scans can be reconstructed into three-dimensional
(3D) recreations of the LA allowing for further analysis and quantification of the LA scar
formation following RF ablation.
Objectives:
Primary Objective
• To evaluate the impact of pre-ablation structural remodeling (fibrosis) on scar formation
and progression in the LA as assessed by DE-MRI in patients who have undergone successful
open irrigated cooled-tipped RF ablation of paroxysmal atrial fibrillation (PAF), using
observational, longitudinal data from the University of Utah Comprehensive Arrhythmia
Research & Management (CARMA) Center supported AFIB database (approved IRB #20347) over a
12-month follow up period.
Secondary Objectives
- To determine if secondary variables, such as total ablation time, number of lesions,
power delivered, and impedance, may play a significant role in catheter induced scar
formation.
- To promulgate future research opportunities in the field of AF, particularly with
regards to possible early intervention measures that may impact its progression.
- To adapt treatments aimed at patients with AF who are diagnosed at earlier stages.
- To use DE-MRI to further the knowledge and understanding of RF ablation therapy and to
better understand the benefits and longitudinal effects of using scar formation to
eliminate the fibrotic tissue that conducts the impulses which leads to AF.
;
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
| Completed |
NCT04571385 -
A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
|
Phase 2 | |
| Completed |
NCT05366803 -
Women's Health Initiative Silent Atrial Fibrillation Recording Study
|
N/A | |
| Completed |
NCT02864758 -
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
|
||
| Recruiting |
NCT05442203 -
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
|
N/A | |
| Completed |
NCT05599308 -
Evaluation of Blood Pressure Monitor With AFib Screening Feature
|
N/A | |
| Completed |
NCT03790917 -
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
|
||
| Enrolling by invitation |
NCT05890274 -
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
|
N/A | |
| Recruiting |
NCT05266144 -
Atrial Fibrillation Patients Treated With Catheter Ablation
|
||
| Recruiting |
NCT05316870 -
Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation
|
N/A | |
| Not yet recruiting |
NCT06023784 -
The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Recruiting |
NCT04092985 -
Smart Watch iECG for the Detection of Cardiac Arrhythmias
|
||
| Completed |
NCT04087122 -
Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures
|
N/A | |
| Completed |
NCT06283654 -
Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
|
||
| Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|
||
| Completed |
NCT04546763 -
Study Watch AF Detection At Home
|
||
| Completed |
NCT03761394 -
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
|
N/A |